4 results
Approved WMOCompleted
Primary objectives:• To evaluate the safety and tolerability of BMS-914143 as measured by the frequency of SAEs and discontinuations due to AEs;• To assess the HBeAg seroconversion rate at 24 weeks off treatment (Week 72).Secondary objective• To…
Approved WMOPending
To evaluate the safety and tolerability of crovalimab compared witheculizumab
Approved WMOPending
To evaluate the efficacy of crovalimab compared to eculizumab
Approved WMOCompleted
We aim to investigate the clinical benefit of cytokine adsorption on post-cardiothoracic surgery vasoplegic syndrome.